FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology, namely to screening antitumour preparations in vitro on a multicomponent cell test system. Method involves co-cultivation of tumor, stromal and immune cells on any of the known extracellular matrix analogues to produce a multicomponent cell co-culture (test system). Then the analyzed substance is added to the obtained multicomponent cell co-culture, incubation is performed, antitumor activity of the test substance is determined by analyzing the viability of the multicomponent cell co-culture using known methods of cell biology with obtaining results on the presence or absence of anticancer activity of the test substance with subsequent extraction of promising substances with high anticancer activity for further stages of preclinical screening or refusal of further screening of the analyzed substance in case the analyzed substance has no evident antitumour activity.
EFFECT: invention provides higher effectiveness of primary screening of substances with potential anti-tumor activity.
1 cl, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR INCREASING THE PROLIFERATIVE POTENTIAL OF THREE-DIMENSIONAL TUMOR CELL CULTURES | 2021 |
|
RU2782600C1 |
METHOD OF ASSESSING THE SPECIFICITY OF BIOLOGICAL MOLECULES IN VITRO | 2022 |
|
RU2798541C1 |
METHOD OF SELECTING MEDICINAL PRODUCTS FOR PHARMACOLOGICAL INDUCTION OF MITOCHONDRIAL DYSFUNCTION IN MACROPHAGES FOR ANTITUMOR THERAPY | 2023 |
|
RU2810558C1 |
METHOD OF SUPPRESSING GROWTH OF TUMOURS WITH GENETICALLY MODIFIED VERSION OF TRAIL CYTOKINE | 2019 |
|
RU2727059C1 |
METHOD OF PRODUCING A MEDICINAL PREPARATION BASED ON HUMAN CELL VESICLES | 2015 |
|
RU2605853C1 |
APPLICATION OF HUMAN SKIN MELANOMA CELL LINE mel Cher AS POSITIVE MODEL OF VASCULOGENIC MIMICRY | 2009 |
|
RU2404243C1 |
METHOD OF OBTAINING MULTICOMPONENT SPHEROIDS FOR IN VITRO MODELING OF HIGHLY AND MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA OF THE SKIN OR ORGANS OF THE HUMAN HEAD AND NECK | 2022 |
|
RU2798548C1 |
APPLICATION OF MEMBRANE VESICLES OF MULTIPOTENT STROMAL CELLS INDUCED BY B CYTOCHALASIN, FOR RESTORATION AND INCREASE OF MITOCHONDRIAL FUNCTION | 2019 |
|
RU2727540C1 |
HUMAN OVARIAN CANCER CELL LINE 533 OOS | 2017 |
|
RU2650759C1 |
CULTURE MEDIUM FOR PRIMARY EPITHELIAL CELLS OF MAMMARY GLAND, METHOD OF CULTIVATION AND USE THEREOF | 2019 |
|
RU2819362C1 |
Authors
Dates
2019-07-24—Published
2018-08-17—Filed